ArticleChronic diseases and translational medicine2017

Current progress and outcomes of clinical trials on using epidermal growth factor receptor-tyrosine kinase inhibitor therapy in non-small cell lung cancer patients with brain metastases.

Ling-Ling Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.